ExodusPoint Capital Management’s Agios Pharmaceuticals AGIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,553
| Closed | -$309K | – | 1350 |
|
|
2025
Q1 | $309K | Buy |
+10,553
| New | +$309K | ﹤0.01% | 1163 |
|
|
2024
Q2 | – | Sell |
-101,612
| Closed | -$2.97M | – | 1342 |
|
|
2024
Q1 | $2.97M | Buy |
101,612
+498
| +0.5% | +$14.6K | 0.02% | 466 |
|
|
2023
Q4 | $2.25M | Buy |
+101,114
| New | +$2.25M | 0.01% | 504 |
|
|
2023
Q3 | – | Sell |
-120,363
| Closed | -$3.41M | – | 1598 |
|
|
2023
Q2 | $3.41M | Sell |
120,363
-78,003
| -39% | -$2.21M | 0.03% | 517 |
|
|
2023
Q1 | $4.56M | Buy |
198,366
+184,341
| +1,314% | +$4.23M | 0.04% | 463 |
|
|
2022
Q4 | $394K | Buy |
+14,025
| New | +$394K | 0.01% | 1227 |
|
|
2022
Q3 | – | Sell |
-60,238
| Closed | -$1.34M | – | 1804 |
|
|
2022
Q2 | $1.34M | Sell |
60,238
-106,221
| -64% | -$2.35M | 0.02% | 907 |
|
|
2022
Q1 | $4.85M | Buy |
166,459
+155,287
| +1,390% | +$4.52M | 0.06% | 365 |
|
|
2021
Q4 | $367K | Sell |
11,172
-13,806
| -55% | -$454K | ﹤0.01% | 1531 |
|
|
2021
Q3 | $1.15M | Buy |
24,978
+21,016
| +530% | +$970K | 0.02% | 917 |
|
|
2021
Q2 | $218K | Sell |
3,962
-64,711
| -94% | -$3.56M | ﹤0.01% | 1854 |
|
|
2021
Q1 | $3.55M | Sell |
68,673
-2,928
| -4% | -$151K | 0.05% | 351 |
|
|
2020
Q4 | $3.1M | Buy |
71,601
+41,829
| +140% | +$1.81M | 0.03% | 357 |
|
|
2020
Q3 | $1.04M | Sell |
29,772
-30,136
| -50% | -$1.05M | 0.02% | 611 |
|
|
2020
Q2 | $3.2M | Buy |
+59,908
| New | +$3.2M | 0.08% | 259 |
|
|
2019
Q2 | – | Sell |
-12,621
| Closed | -$851K | – | 1042 |
|
|
2019
Q1 | $851K | Buy |
+12,621
| New | +$851K | 0.06% | 209 |
|